Mark Lodish - Profile and Investment Details

Investor Profile

Mark Lodish is a Angel/Individual based in New York City, New York, United States with a diverse investment portfolio that includes companies such as IRX Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals, Autogenomics, Natrogen Therapeutics, Paxos, Poachable, Tradelegs, Chronicled, PeerStreet, Tory Burch, Kroll Bond Rating Agency, Plated, Veem, Air Lease, Opendoor, Hello Alfred, Next Jump, Common, Jetty, Digital Currency Group, Watford Re, Capitalspring, Super, Reonomy, LoftSmart AngelPad 10, PlantPV, FCB Financial Holdings. Over time, Mark Lodish has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Mark Lodish is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Social Games, E-commerce, Enterprise Software, Digital Media, Retail, Analytics, Mobile, Energy Efficiency, Clean Technology, Gamification, Data Visualization, Communities, FinTech, Consumer Internet, Quality Assurance, Financial Services, Social Media, SaaS, Big Data, Real Estate, Social Commerce, Personal Health, Health and Wellness may find it worthwhile to explore potential connections with Mark Lodish, as their portfolio suggests a familiarity and interest in this area.

Understanding Mark Lodish’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.